The role of clusterin and the variant rs11136000_T throughout the spectrum of Alzheimer’s disease
Our work shows significant correlation between CSF clusterin and the main AD biomarkers (PET and CSF) and synaptic proteins before disease onset, in subjects at high risk for the disease. In the later stage of the disease, clusterin protein and CLU mRNA levels are increased as a function of genotype and disease status, suggesting that CLU may play a protective role by increases in gene expression in the CNS.
Authors
- Marina Tedeschi Dauar (ORCID: https://orcid.org/0000-0002-1101-8236)
- Judes Poirier
- Anne Labonté (ORCID: https://orcid.org/0000-0001-8076-7540)
- Cynthia Picard (ORCID: https://orcid.org/0000-0003-1107-6839)
- Sylvia Villeneuve (ORCID: https://orcid.org/0000-0003-2338-0467)
Institutions
- Ministry of Education (BR)
- Douglas Mental Health University Institute (CA)
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior (BR)
- McGill University (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.089488
- Primary Topic
- Clusterin in disease pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00